Leading Japanese dietary supplements, pharmaceuticals and ingredients contract manufacturer API crafts superior products for Asian well-being
As health-conscious consumers turn to dietary supplements and herbal products, region’s emerging markets are becoming the perfect hub for seasoned nutraceutical industry players seeking new horizons
Country Business Reports interviews and articles by Discovery Reports www.discoveryreports.com
Nutraceuticals, coined from “nutrition” and “pharmaceuticals”, has become a global multibillion-dollar industry valued at more than US$180 billion last year and forecast to expand 7.3 per cent annually until 2021. As health-conscious consumers turn to dietary supplements and herbal products, Asia’s emerging markets are becoming the perfect hub for seasoned nutraceutical industry players seeking new horizons.
One such player is leading Japanese dietary supplements, pharmaceuticals and ingredients contract manufacturer API. Named after the Latin root for bee, API pioneered Japan’s bee-keeping industry by introducing Western bees to the Land of the Rising Sun.
Tracing its roots back to 1907 amid the famous milk vetch flowers of Gifu prefecture, API has since upgraded its core offerings of nutrient-rich bee-related products such as honey and propolis. Best known for its signature royal jelly, the original equipment manufacturer (OEM) has expanded its portfolio to include health foods, drinks, antibiotics and powdered and freeze-dried health ingredients.
API is the total solutions partner from material procurement and development to marketing and quality assurance services – catering to major clients such as Coca-Cola (Japan) and Yakult.
“We are the leading company among dietary supplement OEMs in Japan, well known for our highly recommendable technologies, standards and specialist expertise accumulated through years of hard work and research,” says president Takahiko Nonogaki. “We are highly acknowledged for creating a Japanese standard for safety and quality – one that has influenced not just Asian, but Western standards.”
API has a significant footprint across the mainland and Hong Kong through affiliate companies and a subsidiary. Eyeing to expand into Malaysia and Thailand, the company has set its sights on a business increase in Asia over the next five years. It welcomes partners across the region with strong market access to the domestic dietary supplement and pharmaceuticals industries.
“Healthy ageing is our aim,” Nonogaki says. “We are happy to collaborate with other institutions, and dispatch our technologies globally to help improve human well-being.”